Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Structural basis for lysophosphatidylserine recognition by GPR34
by
Shihoya, Wataru
, Sano, Fumiya K
, Uwamizu, Akiharu
, Nureki, Osamu
, Chen, Luying
, Kawana, Hiroki
, Kawahara, Ryo
, Tamaki Izume
, Kobayashi, Kazuhiro
, Okamoto, Hiroyuki H
, Kise, Yoshiaki
, Ohwada, Tomohiko
, Omi, Jumpei
, Yaginuma, Shun
, Tanaka, Tatsuki
, Aoki, Junken
in
Antineoplastic drugs
/ Antitumor agents
/ Biochemistry
/ Drug development
/ Electron microscopy
/ Fatty acids
/ G protein-coupled receptors
/ Hydrophobicity
/ Immunomodulation
/ Ligands
/ Oleic acid
/ Physiology
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structural basis for lysophosphatidylserine recognition by GPR34
by
Shihoya, Wataru
, Sano, Fumiya K
, Uwamizu, Akiharu
, Nureki, Osamu
, Chen, Luying
, Kawana, Hiroki
, Kawahara, Ryo
, Tamaki Izume
, Kobayashi, Kazuhiro
, Okamoto, Hiroyuki H
, Kise, Yoshiaki
, Ohwada, Tomohiko
, Omi, Jumpei
, Yaginuma, Shun
, Tanaka, Tatsuki
, Aoki, Junken
in
Antineoplastic drugs
/ Antitumor agents
/ Biochemistry
/ Drug development
/ Electron microscopy
/ Fatty acids
/ G protein-coupled receptors
/ Hydrophobicity
/ Immunomodulation
/ Ligands
/ Oleic acid
/ Physiology
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Structural basis for lysophosphatidylserine recognition by GPR34
by
Shihoya, Wataru
, Sano, Fumiya K
, Uwamizu, Akiharu
, Nureki, Osamu
, Chen, Luying
, Kawana, Hiroki
, Kawahara, Ryo
, Tamaki Izume
, Kobayashi, Kazuhiro
, Okamoto, Hiroyuki H
, Kise, Yoshiaki
, Ohwada, Tomohiko
, Omi, Jumpei
, Yaginuma, Shun
, Tanaka, Tatsuki
, Aoki, Junken
in
Antineoplastic drugs
/ Antitumor agents
/ Biochemistry
/ Drug development
/ Electron microscopy
/ Fatty acids
/ G protein-coupled receptors
/ Hydrophobicity
/ Immunomodulation
/ Ligands
/ Oleic acid
/ Physiology
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Structural basis for lysophosphatidylserine recognition by GPR34
Paper
Structural basis for lysophosphatidylserine recognition by GPR34
2023
Request Book From Autostore
and Choose the Collection Method
Overview
GPR34 is a recently identified G-protein coupled receptor, which has an immunomodulatory role and recognizes lysophosphatidylserine (LysoPS) as a putative ligand. Here, we report cryo-electron microscopy structures of human GPR34-Gi complex bound with either the LysoPS analogue S3E-LysoPS, which contains an ethoxy group at the sn-1 position, or M1, a derivative of S3E-LysoPS in which oleic acid is substituted with a metabolically stable aromatic fatty acid surrogate. In both structures, the ligand-binding pocket is laterally open toward the membrane, allowing lateral entry of lipidic agonists into the cavity. The amine and carboxylate groups of the serine moiety are recognized by the charged residue cluster, and the aromatic fatty acid surrogate of M1 forms stable hydrophobic interactions with the cavity, thus acting as a superagonist. Molecular dynamics simulations further account for the LysoPS-regioselectivity of GPR34. Thus, using a series of structural and physiological experiments, we provide evidence that chemically unstable 2-acyl LysoPS is the physiological ligand for GPR34, suggesting its short signal duration. Overall, we anticipate the present structures will pave the way for development of novel anticancer drugs that specifically target GPR34.Competing Interest StatementO.N. is a co-founder and scientific advisor for Curreio. All other authors declare no competing interests.
Publisher
Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
This website uses cookies to ensure you get the best experience on our website.